Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cytosorbents Cor (CTSO)

Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cytosorbents Cor 305 COLLEGE ROAD EAST PRINCETON NJ 08540 USA

www.cytosorbents.com P: 732-329-8885 F: 732-329-8650

Description:

CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 44,477
Enterprise Value, $K 35,387
Shares Outstanding, K 54,306
Annual Sales, $ 36,350 K
Annual Net Income, $ -28,510 K
Last Quarter Sales, $ 8,670 K
Last Quarter Net Income, $ -5,830 K
EBIT, $ -31,210 K
EBITDA, $ -29,180 K
60-Month Beta 0.58
% of Insider Shareholders 8.10%
% of Institutional Shareholders 32.87%
Float, K 49,907
% Float 91.90%
Short Volume Ratio 0.41

Growth:

1-Year Return -67.10%
3-Year Return -90.42%
5-Year Return -87.62%
5-Year Revenue Growth 61.56%
5-Year Earnings Growth -14.29%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.12 on 03/14/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm -0.64
EPS Growth vs. Prev Qtr 42.86%
EPS Growth vs. Prev Year -1,100.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 12/05/14

CTSO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -120.24%
Return-on-Assets % -54.11%
Profit Margin % -78.43%
Debt/Equity 0.22
Price/Sales 1.21
Price/Cash Flow N/A
Price/Book 1.54
Book Value/Share 0.52
Interest Coverage -0.23
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar